PortfoliosLab logoPortfoliosLab logo
TNYA vs. DFTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TNYA vs. DFTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tenaya Therapeutics, Inc. (TNYA) and Definium Therapeutics, Inc (DFTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TNYA achieves a 4.05% return, which is significantly lower than DFTX's 225.02% return.


TNYA

1D
-1.29%
1M
-5.92%
6M
-4.44%
YTD
4.05%
1Y
10.39%
3Y*
-45.80%
5Y*
-45.47%
10Y*
ALL TIME*
-48.00%

DFTX

1D
-2.18%
1M
-1.52%
6M
157.82%
YTD
225.02%
1Y
415.64%
3Y*
107.23%
5Y*
10Y*
ALL TIME*
42.51%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$64.44M$84.24M$99.34M
$1.19M$2.08M$2.83M

TNYA vs. DFTX - Yearly Performance Comparison


2026 (YTD)2025202420232022
TNYA
Tenaya Therapeutics, Inc.
4.05%-50.24%-55.86%61.19%-64.61%
DFTX
Definium Therapeutics, Inc
225.02%92.39%90.16%66.36%-78.74%

Correlation

The correlation between TNYA and DFTX is 0.10, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.10

Correlation (3Y)
Balances recent behavior with more history.

0.29

Correlation (All Time)
Calculated using the full available price history since Jul 11, 2022

0.28

The correlation between TNYA and DFTX shifts across timeframes, from 0.10 (1 year) to 0.29 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TNYA:

$160.64M

DFTX:

$4.75B

EPS

TNYA:

-$0.47

DFTX:

-$2.51

PB Ratio

TNYA:

1.51

DFTX:

16.98

Total Revenue (TTM)

TNYA:

$225.00K

DFTX:

$0.00

Gross Profit (TTM)

TNYA:

$0.00

DFTX:

$0.00

EBITDA (TTM)

TNYA:

-$78.62M

DFTX:

-$206.36M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TNYA vs. DFTX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TNYA
TNYA Risk / Return Rank: 5252
Overall Rank
TNYA Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
TNYA Sortino Ratio Rank: 5858
Sortino Ratio Rank
TNYA Omega Ratio Rank: 5656
Omega Ratio Rank
TNYA Calmar Ratio Rank: 4848
Calmar Ratio Rank
TNYA Martin Ratio Rank: 4747
Martin Ratio Rank

DFTX
DFTX Risk / Return Rank: 9999
Overall Rank
DFTX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
DFTX Sortino Ratio Rank: 9999
Sortino Ratio Rank
DFTX Omega Ratio Rank: 9797
Omega Ratio Rank
DFTX Calmar Ratio Rank: 9999
Calmar Ratio Rank
DFTX Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TNYA vs. DFTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tenaya Therapeutics, Inc. (TNYA) and Definium Therapeutics, Inc (DFTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TNYADFTXDifference
Sharpe ratioReturn per unit of total volatility

-4.70

Sortino ratioReturn per unit of downside risk

-4.13

Omega ratioGain probability vs. loss probability

1.12

1.60

-0.48

Calmar ratioReturn relative to maximum drawdown

0.13

15.40

-15.27

Martin ratioReturn relative to average drawdown

0.18

47.19

-47.01

TNYA vs. DFTX - Sharpe Ratio Comparison

The current TNYA Sharpe Ratio is 0.09, which is lower than the DFTX Sharpe Ratio of 4.79. The chart below compares the historical Sharpe Ratios of TNYA and DFTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TNYA vs. DFTX - Drawdown Comparison

The maximum TNYA drawdown since its inception was -98.69%, which is greater than DFTX's maximum drawdown of -86.01%. Use the drawdown chart below to compare losses from any high point for TNYA and DFTX.


Loading charts...

Drawdown Indicators


TNYADFTXDifference

Max Drawdown

Largest peak-to-trough decline

-98.69%

-86.01%

-12.68%

Max Drawdown (1Y)

Largest decline over 1 year

-73.81%

-24.79%

-49.02%

Max Drawdown (3Y)

Largest decline over 3 years

-94.30%

-58.38%

-35.92%

Max Drawdown (5Y)

Largest decline over 5 years

-98.69%

Current Drawdown

Current decline from peak

-97.50%

-10.18%

-87.32%

Average Drawdown

Average peak-to-trough decline

-82.55%

-49.74%

-32.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

52.56%

8.09%

+44.47%

Volatility

TNYA vs. DFTX - Volatility Comparison

Tenaya Therapeutics, Inc. (TNYA) has a higher volatility of 17.00% compared to Definium Therapeutics, Inc (DFTX) at 16.10%. This indicates that TNYA's price experiences larger fluctuations and is considered to be riskier than DFTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TNYADFTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.00%

16.10%

+0.90%

Volatility (6M)

Calculated over the trailing 6-month period

67.10%

56.99%

+10.11%

Volatility (1Y)

Calculated over the trailing 1-year period

107.03%

79.66%

+27.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

107.78%

87.09%

+20.69%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

108.16%

87.09%

+21.07%

Dividends

TNYA vs. DFTX - Dividend Comparison

Neither TNYA nor DFTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TNYA vs. DFTX - Financials Comparison

This section allows you to compare key financial metrics between Tenaya Therapeutics, Inc. and Definium Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


TNYA and DFTX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TNYA has higher volatility (17.00%) compared to DFTX (16.10%). In terms of maximum drawdown, TNYA dropped -98.69% vs DFTX's -86.01%.

DFTX currently has the higher Sharpe Ratio (4.79 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TNYA and DFTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer